Please assess the completion status of the following clinical trial:

Trial Title: TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Attending 1 of 29 participating HIV clinics~* Confirmed HIV infection~* Age \> 15 years~Exclusion Criteria:~* Current active TB disease~* TB infection within 2 years~* Hepatitis

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: NO_INTERVENTION): Subjects in clinics that have not received the intervention
- 2 (Type: EXPERIMENTAL): Subjects at clinics that have received the intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).